Press release
US Clinical Trial Services Market worth US$39.61 billion by 2030 with 9.2% CAGR
Key players in the US clinical trial services market include IQVIA Inc. (US), Thermo Fisher Scientific Inc. (US), Fortrea (US), Syneos Health (US), Laboratory Corporation of America Holdings (US), Medpace (US), Frontage Labs (US), Pharmaron (US)
The global US Clinical Trial Services Market [https://www.marketsandmarkets.com/PressReleases/us-clinical-trial-services-market.asp?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=usclinicaltrialservicesmarket] is expected to reach US$39.61 billion by 2030 from US$25.57 billion in 2025, at a CAGR of 9.2% during the forecast period. The growth in the US clinical trial services market is fueled by various factors, such as a well-established pharmaceutical industry, increased demand for clinical trials, high R&D expenditure, and the rising outsourcing of clinical and laboratory testing services by market players.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=405 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=405&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=usclinicaltrialservicesmarket]
Browse in-depth TOC on "US Clinical Trial Services Market"
163 - Tables
62 - Figures
220 - Pages
The small molecules segment accounted for the largest share of the US clinical trial services market by modality during the forecast period.
Based on modality, the US clinical trial services market is divided into small molecules, biologics, and medical devices. The small molecule segment holds a dominant share of the US clinical trial service market. Cost efficiency, streamlined development timelines, proven clinical success rates coupled with strong demand for targeted therapies, oral drugs, and generics reinforce their commercial viability and long-term market leadership and are contributing to the growth of the segment.
The oncology subsegment accounted for the largest share of the US clinical trial service's therapy area segment in 2024.
Based on therapy area, the US clinical trial services market is segmented into oncology, neurology, infectious diseases, cardiovascular system (CVS) disorders, metabolic disorders/endocrinology, immunological disorders, respiratory disorders, psychiatry, dermatology, hematology, ophthalmology, gastrointestinal diseases, genitourinary & women's health, and other therapeutic areas. In 2024, the oncology segment dominated the US clinical trial services market. The increase in cancer cases due to aging populations and lifestyle factors, supported by rising demand for new treatments, high commercial potential of oncology drugs, and the growing adoption of biomarker-driven trials, have bolstered the prominence of the oncology segment.
The phase III segment is expected to account for the largest share of the phase segment in the US clinical trial services market in 2024.
Based on phase, the US clinical trial services market is segmented into Phase I, Phase II, Phase III, and Phase IV. The Phase III segment is likely to grow at a faster CAGR during the forecast period of 2024-2029. High patient enrolment, significant financial investment, and increasing complexity in oncology, neurology, and rare disease trials have fueled the growth of the phase III segment.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=405 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=405&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=usclinicaltrialservicesmarket]
Key players in the US clinical trial services market include IQVIA Inc. (US), Thermo Fisher Scientific Inc. (US), Fortrea (US), Syneos Health (US), Laboratory Corporation of America Holdings (US), Medpace (US), Frontage Labs (US), Pharmaron (US), Parexel International Corporation (US), Worldwide Clinical Trials (US), Allucent (US), Premier Research (US), Clario (US), KCR S.A. (US), Rho, Inc. (US) and Advanced Clinical (US) among others.
Study Coverage:
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the US clinical trial services market. A detailed analysis of the key industry players has been done to provide insights into their business overviews; service offerings; key strategies; acquisitions, new service launches, expansions, agreements, and recent developments associated with the US clinical trials services market.
For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=405&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=usclinicaltrialservicesmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=us-clinical-trial-services-market-worth-us3961-billion-by-2030-with-92-cagr]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/PressReleases/us-clinical-trial-services-market.asp
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Clinical Trial Services Market worth US$39.61 billion by 2030 with 9.2% CAGR here
News-ID: 3972370 • Views: …
More Releases from ABNewswire
InsureAustinTX.com Launches to Provide Smart Insurance Solutions for Austin Fami …
InsureAustinTX.com, the newest online platform from Baxter Insurance Agency, Inc., is set to launch on January 13, 2026, offering Austin residents a streamlined way to find and compare local insurance options for auto and home coverage.
AUSTIN, TX - Jan 13, 2026 - Baxter Insurance Agency, Inc., a trusted name in Texas insurance for over four decades, is proud to announce the launch of its latest website, InsureAustinTX.com. This new platform…
Best ADU Builders in St. Petersburg, FL (2026 Review): Zoning, Cost & Contractor …
A 2026 market review examines how homeowners in St. Petersburg, Florida are evaluating ADU builders under stricter zoning and permitting enforcement. The report compares contractor types, highlights common project failures, and explains why design-build firms are increasingly preferred for compliant accessory dwelling unit construction.
ST. PETERSBURG, FL - January 13, 2026 - As demand for accessory dwelling units (ADUs) continues to rise across St. Petersburg and Pinellas County, homeowners are facing…
How to Draw a Corgi: A Creative Guide to Relaxation and Mindfulness
New Book Confessions of a Corgi Doodler Turns Simple Sketches Into a Philosophy for Creative Living
MARIETTA, GA - The new book Confessions of a Corgi Doodler [https://www.amazon.com/Confessions-Corgi-Doodler-Nancy-Kondos/dp/1966972717/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.eK5vqZKYyVTf8-wHEYO8Bw.pJTT3UgaTroxKgcIHzvQiAWCz1FNpLKHBjvk9qWGepE&qid=1765308929&sr=1-1] begins with a single instruction: lose your predictions. Let the pen dance. What follows is not just a guide to drawing the charming, short legged dog, but a series of illustrated revelations on creativity itself. Published by Author's Tranquility Press, this volume by…
Amidst the Silence of Loss A New Voice Emerges
The new book "Live Again: A Widow's Guide to Healing and Recovery" by Alene Maag offers a compassionate and practical resource for the journey through widowhood.
MARIETTA, GA - In the quiet aftermath of a spouse's death, a crushing duality descends: an ocean of private grief and a mountain of public, practical demands. This isolating space now has a thoughtful new companion. "Live Again: A Widow's Guide to Healing and Recovery…
More Releases for Corporation
Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S …
A fresh report titled “Endotherapy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report.
The global endotherapy devices market is projected to reach…
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor …
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally.
Introduction
Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’.
Get PDF for more Professional and Technical insights…
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, …
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing at…
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif …
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices market…
Digital Living Room Market 2017 - 2025 : Sharp Corporation, BenQ Corporation, So …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
